Ethical Considerations Observed By Authors As They Submit Their Articles On Oncotarget

Oncotarget is a medical journal, which was founded in 2010. The journal is published on a weekly basis. It covers all issues related to oncology. Oncotarget’s chief editors are Andrei Gudkov and Mikhail Blagosklonny of Institute of Cancer, Roswell Park. The journal applies a standardized license to its publications. Authors are allowed to maintain ownership rights of their articles. They can give permission to anyone to download, modify, copy, reuse, reprint and distribute their submitted materials. The editors and the publisher expect the authors to adhere to the stipulated ethical considerations to qualify to submit their articles to Oncotarget. By following the set standards, the journal ensures that only legit articles having accurate information are published.

To begin with, authors must describe the accurate results of their research and give the scientific explanation of their work. The submitted document should have enough references and details that allow others to reproduce them. The opinion of the editors should be acknowledged and the reviewed articles portray objectivity, accuracy and comprehensiveness. Authors who intentionally submit false or inaccurate information will be considered unethical. Oncotarget is published by Impact Journals

On the same note, persons listed as authors must be responsible to the public in their conception, proposal, acquisition, implementation, analysis and interpretation of data. Similarly, they must have gone through and approved the final copy of the manuscript, and accept that it should be submitted for publication. Notably, the persons that contributed ideas on the paper and do not meet the requirements for authorship should not be listed as authors. The authors should instead recognize them in the acknowledgment section.

Consequentially, writers should give proper recognition to other contributors in their work. They should also provide citations of the sources that they used to complete their papers. Privately owned information from correspondence, discussion, and conversation with third parties must only be used after obtaining their permission. Nevertheless, writers should avoid using information from confidential sources like grand applications and refereeing manuscripts unless they have received written authorization of the authors who were involved in that work. Conclusively, authors that publish their papers through Oncotarget have an obligation to inform the editors or publisher when they discover inaccuracies or significant errors after they have already submitted their work. Download output styles at

InnovaCare Health & It’s Progressive Leadership

InnovaCare Health, a leading Medicare plans and physician practices services provider, expanded its leadership team in 2016 by adding three executives. Jonathan Meyers will be serving as the new chief actuary officer, Penelope Kokkinides as the chief administrative officer and Mike Sortino as the chief accounting officer. This addition brings extra experience and qualities to the current leadership team headed by Richard Shinto, the organization’s President, and chief executive officer. Learn more about the company at

Dr. Shinto has over 20 years’ worth of experience in clinical and operational healthcare. Richard Shinto began his medical career in Southern California as an internist and pulmonologist. Before joining InnovaCare, Dr. Shinto had served several organizations in the clinical and operational healthcare industry in an executive position. Among the groups he had served, NAMM California as the chief medical officer, medical Pathways Management Company as the chief operating officer and chief medical officer, MedPartners as a Corporate Vice President and Cal Optima Health Plan as the chief medical officer. Due to his commitment to availing and advancing access to health care for the underserved, Dr. Shinto was awarded in the “A Tribute to Caring” gala held at Western University of Health Sciences. Dr. Shinto received his medical degree from the State University of New York and holds an MBA from the University of Redlands.

Penelope Kokkinides, the new chief administrative officer, has more than two decades of healthcare experience. She has extensive knowledge and expertise in government programs like Medicaid and Medicare. Kokkinides specializes in managing health care processes and developing clinical programs to boost organizational infrastructure. Before joining InnovaCare, Kokkinides worked at Centerlight HealthCare where she was the executive vice president and chief operating officer. Kokkinides has also served at Touchstone Health as the chief operating officer and at AmeriChoice, a division of UnitedHealth Group, as the Corporate Vice President.

About InnovaCare, Inc.

InnovaCare, Inc. is a health service provider operating in Puerto Rico and majorly focusing on Medicare Advantage and Medicaid Programs. The organization has more than 200,000 individuals under its MMM Healthcare and PMC Medicare Choice health plans. Under its Medicaid Program, InnovaCare manages two schemes under the Government Health Plan in Puerto Rico. The organization employs the services of a network of over 7,500 providers to serve its clients effectively. InnovaCare is committed to providing access to quality health care by developing sustainable and cost efficient models and integrating advanced technologies in its services. Read this article about Innovacare at Yahoo Finance